309 related articles for article (PubMed ID: 16283217)
1. Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit.
Tena D; Carranza R; Barberá JR; Valdezate S; Garrancho JM; Arranz M; Sáez-Nieto JA
Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):727-32. PubMed ID: 16283217
[TBL] [Abstract][Full Text] [Related]
2. Achromobacter bacteraemia outbreak in a paediatric onco-haematology department related to strain with high surviving ability in contaminated disinfectant atomizers.
Hugon E; Marchandin H; Poirée M; Fosse T; Sirvent N
J Hosp Infect; 2015 Feb; 89(2):116-22. PubMed ID: 25499179
[TBL] [Abstract][Full Text] [Related]
3. Outbreak of Achromobacter xylosoxidans pseudobacteremia in a neonatal care unit related to contaminated chlorhexidine solution.
Molina-Cabrillana J; Santana-Reyes C; González-García A; Bordes-Benítez A; Horcajada I
Eur J Clin Microbiol Infect Dis; 2007 Jun; 26(6):435-7. PubMed ID: 17516103
[No Abstract] [Full Text] [Related]
4. Achromobacter xylosoxidans, an emerging pathogen in catheter-related infection in dialysis population causing prosthetic valve endocarditis: a case report and review of literature.
Ahmed MS; Nistal C; Jayan R; Kuduvalli M; Anijeet HK
Clin Nephrol; 2009 Mar; 71(3):350-4. PubMed ID: 19281752
[TBL] [Abstract][Full Text] [Related]
5. Salvage of long-term central venous catheters during an outbreak of Pseudomonas putida and Stenotrophomonas maltophilia infections associated with contaminated heparin catheter-lock solution.
Souza Dias MB; Habert AB; Borrasca V; Stempliuk V; Ciolli A; Araújo MR; Costa SF; Levin AS
Infect Control Hosp Epidemiol; 2008 Feb; 29(2):125-30. PubMed ID: 18179367
[TBL] [Abstract][Full Text] [Related]
6. Investigation and control of an outbreak of Achromobacter xylosoxidans bacteremia.
Behrens-Muller B; Conway J; Yoder J; Conover CS
Infect Control Hosp Epidemiol; 2012 Feb; 33(2):180-4. PubMed ID: 22227988
[TBL] [Abstract][Full Text] [Related]
7. Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome.
Turel O; Kavuncuoglu S; Hosaf E; Ozbek S; Aldemir E; Uygur T; Hatipoglu N; Siraneci R
Braz J Infect Dis; 2013; 17(4):450-4. PubMed ID: 23742802
[TBL] [Abstract][Full Text] [Related]
8. Achromobacter xylosoxidans Bacteremia and Cellulitis: A Report of a Case.
Dai J; Huen AO; Kestenbaum LA; Sarezky MD; Coughlin CC; Yan AC
Pediatr Dermatol; 2015; 32(4):e186-7. PubMed ID: 25973735
[TBL] [Abstract][Full Text] [Related]
9. [Bacteremia caused by Alcaligenes (Achromobacter) xylosoxidans. Description of 3 cases and review of the literature].
Ramos JM; Domine M; Ponte MC; Soriano F
Enferm Infecc Microbiol Clin; 1996; 14(7):436-40. PubMed ID: 8991439
[TBL] [Abstract][Full Text] [Related]
10. Arteriovenous fistula-related bacteremia caused by Achromobacter xylosoxidans in a uremic patient.
Lee WS; Ou TY; Hsieh TC; Chen FL; Jean SS
J Microbiol Immunol Infect; 2015 Oct; 48(5):578-9. PubMed ID: 24856428
[No Abstract] [Full Text] [Related]
11. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome.
Weitkamp JH; Tang YW; Haas DW; Midha NK; Crowe JE
Clin Infect Dis; 2000 Nov; 31(5):1183-7. PubMed ID: 11073750
[TBL] [Abstract][Full Text] [Related]
12. Achromobacter xylosoxidans bacteremia: clinical and microbiological features in a 10-year case series.
Pérez Barragán E; Sandino Pérez J; Corbella L; Orellana MA; Fernández-Ruiz M
Rev Esp Quimioter; 2018 Jun; 31(3):268-273. PubMed ID: 29806765
[TBL] [Abstract][Full Text] [Related]
13. Hospital-acquired pneumonia due to Achromobacter xylosoxidans in the elderly: A single-center retrospective study in Beijing.
Liu C; Guo J; Yan W; Jin Y; Pan F; Fang X; Qin L; Liu C
J Infect Dev Ctries; 2017 Jan; 11(1):10-18. PubMed ID: 28141585
[TBL] [Abstract][Full Text] [Related]
14. Fatal catheter-related bacteremia due to Alcaligenes (Achromobacter) xylosoxidans in a hemodialysis patient.
Turgutalp K; Kiykim A; Ersoz G; Kaya A
Int Urol Nephrol; 2012 Aug; 44(4):1281-3. PubMed ID: 21637989
[No Abstract] [Full Text] [Related]
15. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan.
Shie SS; Huang CT; Leu HS
J Microbiol Immunol Infect; 2005 Aug; 38(4):277-82. PubMed ID: 16118676
[TBL] [Abstract][Full Text] [Related]
16. Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates.
Tsay RW; Lin LC; Chiou CS; Liao JC; Chen CH; Liu CE; Young TG
J Microbiol Immunol Infect; 2005 Jun; 38(3):194-9. PubMed ID: 15986070
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data.
Amoureux L; Bador J; Siebor E; Taillefumier N; Fanton A; Neuwirth C
J Cyst Fibros; 2013 Mar; 12(2):170-6. PubMed ID: 22944724
[TBL] [Abstract][Full Text] [Related]
18. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases.
Gómez-Cerezo J; Suárez I; Ríos JJ; Peña P; García de Miguel MJ; de José M; Monteagudo O; Linares P; Barbado-Cano A; Vázquez JJ
Eur J Clin Microbiol Infect Dis; 2003 Jun; 22(6):360-3. PubMed ID: 12750959
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial outbreak of Sphingomonas paucimobilis bacteremia in a hemato/oncology unit.
Kilic A; Senses Z; Kurekci AE; Aydogan H; Sener K; Kismet E; Basustaoglu AC
Jpn J Infect Dis; 2007 Nov; 60(6):394-6. PubMed ID: 18032843
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological typing of clinical isolates of Achromobacter xylosoxidans: comparison of phenotypic and genotypic methods.
Kaur M; Ray P; Bhatty M; Sharma M
Eur J Clin Microbiol Infect Dis; 2009 Sep; 28(9):1023-32. PubMed ID: 19373499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
